COVID-19 Vaccine Uptake and Intentions Following US Food and Drug Administration Approval of the Pfizer-BioNTech COVID-19 Vaccine

RT @JAMAInternalMed: Contrary to pre-licensure predictions, @HaPPISurveys found that @US_FDA approval of a #COVID19 #vaccine had limited im…

Contrary to pre-licensure predictions, @HaPPISurveys found that @US_FDA approval of a #COVID19 #vaccine had limited impact or demographic differences in vaccination intent. Important to consider when creating public health policy for future ID outbreaks…

In group of 535 vaccine hesitant individuals, FDA approval led to vaccination in 3.6% over next two months. “Our results suggest the full approval of the BNT162b2 COVID-19 vaccine had little immediate impact on vaccination intentions.” https://t.co/zVT4…

RT @celinegounder: 1/ Q: Did full @US_FDA approval of COVID vaccine convince people to get vaccinated? A: No https://t.co/XRZFSuo0FY https:…